UChicago biotech startup gets $2.3M from NIH

Oxalo, launched by faculty and students at the University of Chicago, announced that it has been awarded $2.3 million from the National Institutes of Health.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.